Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.
2.

HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism.

Manches O, Munn D, Fallahi A, Lifson J, Chaperot L, Plumas J, Bhardwaj N.

J Clin Invest. 2008 Oct;118(10):3431-9. doi: 10.1172/JCI34823.

3.

How regulatory T cells work.

Vignali DA, Collison LW, Workman CJ.

Nat Rev Immunol. 2008 Jul;8(7):523-32. doi: 10.1038/nri2343. Review.

4.

Regulatory T cells and immune tolerance.

Sakaguchi S, Yamaguchi T, Nomura T, Ono M.

Cell. 2008 May 30;133(5):775-87. doi: 10.1016/j.cell.2008.05.009. Review.

5.

Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape.

Katz JB, Muller AJ, Prendergast GC.

Immunol Rev. 2008 Apr;222:206-21. doi: 10.1111/j.1600-065X.2008.00610.x. Review.

PMID:
18364004
6.

The Foxp3+ regulatory T cell: a jack of all trades, master of regulation.

Tang Q, Bluestone JA.

Nat Immunol. 2008 Mar;9(3):239-44. doi: 10.1038/ni1572. Review.

7.

Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells.

Lob S, Konigsrainer A, Schafer R, Rammensee HG, Opelz G, Terness P.

Blood. 2008 Feb 15;111(4):2152-4. Epub 2007 Nov 28.

8.

IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells.

Hill M, Tanguy-Royer S, Royer P, Chauveau C, Asghar K, Tesson L, Lavainne F, Rémy S, Brion R, Hubert FX, Heslan M, Rimbert M, Berthelot L, Moffett JR, Josien R, Grégoire M, Anegon I.

Eur J Immunol. 2007 Nov;37(11):3054-62.

9.

Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation.

Jiang A, Bloom O, Ono S, Cui W, Unternaehrer J, Jiang S, Whitney JA, Connolly J, Banchereau J, Mellman I.

Immunity. 2007 Oct;27(4):610-24. Epub 2007 Oct 11.

10.

Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase.

Sharma MD, Baban B, Chandler P, Hou DY, Singh N, Yagita H, Azuma M, Blazar BR, Mellor AL, Munn DH.

J Clin Invest. 2007 Sep;117(9):2570-82.

11.

Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan.

Metz R, Duhadaway JB, Kamasani U, Laury-Kleintop L, Muller AJ, Prendergast GC.

Cancer Res. 2007 Aug 1;67(15):7082-7.

12.

Tolerogenic dendritic cells and the quest for transplant tolerance.

Morelli AE, Thomson AW.

Nat Rev Immunol. 2007 Aug;7(8):610-21. Epub 2007 Jul 13. Review.

PMID:
17627284
13.

Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo.

Villadangos JA, Schnorrer P.

Nat Rev Immunol. 2007 Jul;7(7):543-55. Review.

PMID:
17589544
14.

Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice.

Ball HJ, Sanchez-Perez A, Weiser S, Austin CJ, Astelbauer F, Miu J, McQuillan JA, Stocker R, Jermiin LS, Hunt NH.

Gene. 2007 Jul 1;396(1):203-13. Epub 2007 Apr 18. Erratum in: Gene. 2010 Oct 1;465(1-2):66.

PMID:
17499941
15.

Indoleamine 2,3-dioxygenase and tumor-induced tolerance.

Munn DH, Mellor AL.

J Clin Invest. 2007 May;117(5):1147-54. Review.

16.

Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells.

Curti A, Pandolfi S, Valzasina B, Aluigi M, Isidori A, Ferri E, Salvestrini V, Bonanno G, Rutella S, Durelli I, Horenstein AL, Fiore F, Massaia M, Colombo MP, Baccarani M, Lemoli RM.

Blood. 2007 Apr 1;109(7):2871-7.

17.

HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells.

Boasso A, Herbeuval JP, Hardy AW, Anderson SA, Dolan MJ, Fuchs D, Shearer GM.

Blood. 2007 Apr 15;109(8):3351-9. Epub 2006 Dec 7.

18.

The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function.

Della Chiesa M, Carlomagno S, Frumento G, Balsamo M, Cantoni C, Conte R, Moretta L, Moretta A, Vitale M.

Blood. 2006 Dec 15;108(13):4118-25. Epub 2006 Aug 10.

19.

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells.

Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, Gottlieb PA, Kapranov P, Gingeras TR, Fazekas de St Groth B, Clayberger C, Soper DM, Ziegler SF, Bluestone JA.

J Exp Med. 2006 Jul 10;203(7):1701-11. Epub 2006 Jul 3.

20.

Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells.

Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A, Solomon M, Selby W, Alexander SI, Nanan R, Kelleher A, Fazekas de St Groth B.

J Exp Med. 2006 Jul 10;203(7):1693-700. Epub 2006 Jul 3.

Items per page

Supplemental Content

Write to the Help Desk